Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 12Brain Neoplasms 8Breast Neoplasms 5Agnosia 4Thyroid Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Emergence Delirium 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pain 2Inflammation 2Dexmedetomidine 2Delirium 2Chronic Pain 2Thrombosis 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Sedation 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Pneumoperitoneum 1Pheochromocytoma 1Opioid Consumption, Postoperative 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Magnetic Resonance Imaging 1Enhanced Recovery After Surgery 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cerebrovascular Disorders × Dexmedetomidine × Clear all
NCT02878707 2020-09-22

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

National Taiwan University Hospital

Phase NA Completed
160 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡